1-(3,4-DIMETHOXYPHENYL)-8,9-DIMETHOXY-3-PHENYLPYRROLO[2,1-A]ISOQUINOLINE
![]() |
- $721 - $1003.58
- Product name: 1-(3,4-DIMETHOXYPHENYL)-8,9-DIMETHOXY-3-PHENYLPYRROLO[2,1-A]ISOQUINOLINE
- CAS: 886362-22-7
- MF: C28H25NO4
- MW: 439.5
- EINECS:
- MDL Number:MFCD08056693
- Synonyms:1-(3,4-DIMETHOXYPHENYL)-8,9-DIMETHOXY-3-PHENYLPYRROLO[2,1-A]ISOQUINOLINE;Pyrrolo[2,1-a]isoquinoline, 1-(3,4-dimethoxyphenyl)-8,9-dimethoxy-3-phenyl-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0082462
- Product description1-(3,4-DIMETHOXYPHENYL)-8,9-DIMETHOXY-3-PHENYLPYRROLO[2,1-A]ISOQUINOLINE 95.00%
- Packaging500MG
- Price$1003.58
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11031813
- Product description1-(3,4-Dimethoxyphenyl)-8,9-dimethoxy-3-phenylpyrrolo[2,1-a]isoquinoline 95+%
- Packaging1g
- Price$850
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number046325
- Product description1-(3,4-Dimethoxyphenyl)-8,9-dimethoxy-3-phenylpyrrolo[2,1-a]isoquinoline >95%
- Packaging500mg
- Price$721
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0082462 | 1-(3,4-DIMETHOXYPHENYL)-8,9-DIMETHOXY-3-PHENYLPYRROLO[2,1-A]ISOQUINOLINE 95.00% | 500MG | $1003.58 | 2021-12-16 | Buy |
Crysdot | CD11031813 | 1-(3,4-Dimethoxyphenyl)-8,9-dimethoxy-3-phenylpyrrolo[2,1-a]isoquinoline 95+% | 1g | $850 | 2021-12-16 | Buy |
Matrix Scientific | 046325 | 1-(3,4-Dimethoxyphenyl)-8,9-dimethoxy-3-phenylpyrrolo[2,1-a]isoquinoline >95% | 500mg | $721 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): |
![]() |
|||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||
Precautionary statements: |
|